Dr Peter (Pete) Charlton has a long history of working in biotech and pharma, and most recently ran the UK operations for Vertex Pharma. In that role he had line management of the Biology Division - responsible for Protein Biochemistry, Crystallography/Structural Biology, Cell Biology, Enzymology and Pharmacology Leadership and development of UK Research Portfolio from target identification through to nomination of clinical candidate. His focus was mainly oncology and neurodegenerative disease (previous areas have included sepsis and Multiple Sclerosis). Prior to Vertex Pete was at Xenova Group plc for 13 years, latterly as the Head of Biology. Prior to that he was a Senior Research Leader at GlaxoSmithKline for 8 years.
Pete Charlton has a DPhil in Chemistry and Enzymology from the University of Sussex.